Used as a key intermediate in the synthesis of bioactive compounds, particularly in pharmaceutical research targeting anti-inflammatory and anticancer agents. Its structure supports the development of enzyme inhibitors due to its ability to interact with specific protein binding sites. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies, especially in optimizing phthalazinone-based drug candidates. Also utilized in the preparation of receptor modulators affecting central nervous system pathways. Its halogenated aromatic rings enhance binding affinity and metabolic stability in lead compounds.